PharmaCyte Biotech Inc (NASDAQ:PMCB)

2.29
Delayed Data
As of 12:00am ET
 +0.12 / +5.53%
Today’s Change
1.79
Today|||52-Week Range
21.75
-8.40%
Year-to-Date

Stock Price Forecast

There is no forecast data available.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in PharmaCyte Biotech Inc. This rating has held steady since November, when it was downgraded from a Buy rating.Move your mouse over past
months for detail

 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.04
Sales
$0.00
Reporting Date
Jun 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.00%
 
 
 
 
 
Growthannually 0.00%
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.